441 related articles for article (PubMed ID: 21220316)
1. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress.
Aggarwal M; Sommers JA; Shoemaker RH; Brosh RM
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1525-30. PubMed ID: 21220316
[TBL] [Abstract][Full Text] [Related]
2. Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional fanconi anemia pathway.
Aggarwal M; Banerjee T; Sommers JA; Iannascoli C; Pichierri P; Shoemaker RH; Brosh RM
Cancer Res; 2013 Sep; 73(17):5497-507. PubMed ID: 23867477
[TBL] [Abstract][Full Text] [Related]
3. The Werner syndrome protein functions in repair of Cr(VI)-induced replication-associated DNA damage.
Liu FJ; Barchowsky A; Opresko PL
Toxicol Sci; 2009 Aug; 110(2):307-18. PubMed ID: 19487340
[TBL] [Abstract][Full Text] [Related]
4. Targeting an Achilles' heel of cancer with a WRN helicase inhibitor.
Aggarwal M; Banerjee T; Sommers JA; Brosh RM
Cell Cycle; 2013 Oct; 12(20):3329-35. PubMed ID: 24036544
[TBL] [Abstract][Full Text] [Related]
5. Competition between the DNA unwinding and strand pairing activities of the Werner and Bloom syndrome proteins.
Machwe A; Lozada EM; Xiao L; Orren DK
BMC Mol Biol; 2006 Jan; 7():1. PubMed ID: 16412221
[TBL] [Abstract][Full Text] [Related]
6. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
[TBL] [Abstract][Full Text] [Related]
7. WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.
Patro BS; Frøhlich R; Bohr VA; Stevnsner T
J Cell Sci; 2011 Dec; 124(Pt 23):3967-79. PubMed ID: 22159421
[TBL] [Abstract][Full Text] [Related]
8. Functional role of the Werner syndrome RecQ helicase in human fibroblasts.
Dhillon KK; Sidorova J; Saintigny Y; Poot M; Gollahon K; Rabinovitch PS; Monnat RJ
Aging Cell; 2007 Feb; 6(1):53-61. PubMed ID: 17266675
[TBL] [Abstract][Full Text] [Related]
9. Werner protein protects nonproliferating cells from oxidative DNA damage.
Szekely AM; Bleichert F; Nümann A; Van Komen S; Manasanch E; Ben Nasr A; Canaan A; Weissman SM
Mol Cell Biol; 2005 Dec; 25(23):10492-506. PubMed ID: 16287861
[TBL] [Abstract][Full Text] [Related]
10. RECQ1 is required for cellular resistance to replication stress and catalyzes strand exchange on stalled replication fork structures.
Popuri V; Croteau DL; Brosh RM; Bohr VA
Cell Cycle; 2012 Nov; 11(22):4252-65. PubMed ID: 23095637
[TBL] [Abstract][Full Text] [Related]
11. The Werner and Bloom syndrome proteins catalyze regression of a model replication fork.
Machwe A; Xiao L; Groden J; Orren DK
Biochemistry; 2006 Nov; 45(47):13939-46. PubMed ID: 17115688
[TBL] [Abstract][Full Text] [Related]
12. The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.
Mao FJ; Sidorova JM; Lauper JM; Emond MJ; Monnat RJ
Cancer Res; 2010 Aug; 70(16):6548-55. PubMed ID: 20663905
[TBL] [Abstract][Full Text] [Related]
13. Delineation of WRN helicase function with EXO1 in the replicational stress response.
Aggarwal M; Sommers JA; Morris C; Brosh RM
DNA Repair (Amst); 2010 Jul; 9(7):765-76. PubMed ID: 20447876
[TBL] [Abstract][Full Text] [Related]
14. WRN participates in translesion synthesis pathway through interaction with NBS1.
Kobayashi J; Okui M; Asaithamby A; Burma S; Chen BP; Tanimoto K; Matsuura S; Komatsu K; Chen DJ
Mech Ageing Dev; 2010 Jun; 131(6):436-44. PubMed ID: 20600238
[TBL] [Abstract][Full Text] [Related]
15. WRN helicase defective in the premature aging disorder Werner syndrome genetically interacts with topoisomerase 3 and restores the top3 slow growth phenotype of sgs1 top3.
Aggarwal M; Brosh RM
Aging (Albany NY); 2009 Feb; 1(2):219-33. PubMed ID: 20157511
[TBL] [Abstract][Full Text] [Related]
16. Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase.
Futami K; Takagi M; Shimamoto A; Sugimoto M; Furuichi Y
Biol Pharm Bull; 2007 Oct; 30(10):1958-61. PubMed ID: 17917271
[TBL] [Abstract][Full Text] [Related]
17. A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN).
Sommers JA; Kulikowicz T; Croteau DL; Dexheimer T; Dorjsuren D; Jadhav A; Maloney DJ; Simeonov A; Bohr VA; Brosh RM
PLoS One; 2019; 14(1):e0210525. PubMed ID: 30625228
[TBL] [Abstract][Full Text] [Related]
18. The DNA repair endonuclease XPG interacts directly and functionally with the WRN helicase defective in Werner syndrome.
Trego KS; Chernikova SB; Davalos AR; Perry JJ; Finger LD; Ng C; Tsai MS; Yannone SM; Tainer JA; Campisi J; Cooper PK
Cell Cycle; 2011 Jun; 10(12):1998-2007. PubMed ID: 21558802
[TBL] [Abstract][Full Text] [Related]
19. Cellular deficiency of Werner syndrome protein or RECQ1 promotes genotoxic potential of hydroquinone and benzo[a]pyrene exposure.
Garige M; Sharma S
Int J Toxicol; 2014; 33(5):373-81. PubMed ID: 25228686
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of werner and bloom helicases by DNA minor groove binding drugs.
Brosh RM; Karow JK; White EJ; Shaw ND; Hickson ID; Bohr VA
Nucleic Acids Res; 2000 Jun; 28(12):2420-30. PubMed ID: 10871376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
